Skip to main content
Hoopsmachine

Bucks have no timetable on when Giannis Antetokounmpo might return from right calf strain

NBA logoNBA
injury
3 articles from 2 sources

Aggregated coverage · Methodology and corrections

Coverage first published:
Coverage updated:

Follow the teams and players

Compare coverage

Showing 3 of 3 loaded articles. Grouped coverage is not independent confirmation.

  • Bucks have no timetable on when Giannis Antetokounmpo might return from right calf strain

    Giannis Antetokounmpo’s potential return date remains uncertain as the Milwaukee Bucks forward recovers from a calf strain that he had predicted might keep him out for four to six weeks. The two-time MVP also said after the Bucks’ 102-100 loss to Denver on Friday that an MRI would determine he had a calf or soleus strain in his right leg. Bucks coach Doc Rivers confirmed the calf strain diagnosis Monday but didn’t speculate on when Antetokounmpo might return.

    Publisher:Yahoo Sports NBA
    Lead article
    Article published:
  • Bucks release no timetable for Giannis Antetokounmpo return from calf injury

    Antetokounmpo self-diagnosed with a calf strain he said would keep him out 4-6 weeks, but the Bucks are saying nothing.

    Publisher:Yahoo Sports NBAArticle published:
  • Bucks’ Giannis Antetokounmpo has no injury timeline, but won’t be out for season

    Giannis Antetokounmpo had previously stated that the calf injury he is recovering from may sideline him for up to four to six weeks. With the two-time MVP’s shaky history with calf injuries, the Milwaukee Bucks head coach Doc Rivers has claimed that there exists no timeline for his return as things stand. “There’s really no […] The post Bucks’ Giannis Antetokounmpo has no injury timeline, but won’t be out for season appeared first on ClutchPoints .

    Publisher:ClutchPointsArticle published:

Keep up without checking every headline

Basketball digest. Email-only signup. Optional account for league choices.

Teams and players in this story

Open a profile to follow its coverage in your personal feed.

Comments